Literature DB >> 102086

Excretion and biotransformation of carboxymethyl-cysteine in rat, dog, monkey and man.

L B Turnbull, L Teng, J M Kinzie, J E Pitts, F M Pinchbeck, R B Bruce.   

Abstract

1. Following an oral dose of S-carboxymethyl [35S]cysteine monkey (rhesus and African green), rat, dog, and man excreted 77,88,95, and 100% respectively of the 35S radioactivity in urine and 7.0, 2.5, 0.7, and 0.3% in faeces during a 3 to 4 day period. 2. The principal drug-related components excreted were unchanged carboxymethylcysteine, dicarboxymethyl sulphide and inorganic sulphate. 3. Rat, dog, and man excreted primarily dicarboxymethyl sulphide and unchanged carboxymethylcysteine and no inorganic sulphate (rat, 7%). 4. Monkey excreted largely inorganic sulphate, moderate amounts of dicarboxymethyl sulphide and a trace of unchanged drug.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 102086     DOI: 10.3109/00498257809069574

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  5 in total

1.  High pressure liquid chromatographic determination of carbocisteine in human plasma and urine.

Authors:  J Bron
Journal:  Pharm Weekbl Sci       Date:  1986-04-25

2.  Evaluation of proposed sulphoxidation pathways of carbocysteine in man by HPLC quantification.

Authors:  J Brockmöller; B Staffeldt; I Roots
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

3.  Genetic aspects of the polymodally distributed sulphoxidation of S-carboxymethyl-L-cysteine in man.

Authors:  S C Mitchell; R H Waring; C S Haley; J R Idle; R L Smith
Journal:  Br J Clin Pharmacol       Date:  1984-10       Impact factor: 4.335

4.  An investigation of the metabolism of S-carboxymethyl-L-cysteine in man using a novel HPLC-ECD method.

Authors:  E F Karim; J S Millership; D J Temple; A D Woolfson
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1988 Oct-Dec       Impact factor: 2.441

5.  Variation in human metabolism of S-carboxymethylcysteine.

Authors:  R H Waring
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1980       Impact factor: 2.441

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.